Bisoprolol Fumarate Tablet 10 mg

DRUG3 trials

Sponsors

IPCA Laboratories Ltd., University of Arizona

Conditions

CAR T-Cell TherapyCell TherapyDonor Lymphocyte InfusionFastingFedHematopoetic Stem Cell TransplantationLeukemiaLymphoma

Early Phase 1

Exercise as an Immune Adjuvant for Allogeneic Cell Therapies

RecruitingNCT06643221

University of ArizonaCAR T-Cell Therapy, Cell Therapy, Donor Lymphocyte Infusion +3

Start: 2018-01-24End: 2028-12-30Target: 100Updated: 2024-10-16

Phase 1

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fasting Condition

CompletedNCT01741623

IPCA Laboratories Ltd.Fasting

Start: 2012-08-31End: 2012-11-30Updated: 2012-12-05

Bioequivalence Study of Bisoprolol Fumarate Tablet 10 mg Under Fed Condition

CompletedNCT01744873

IPCA Laboratories Ltd.Fed

Start: 2012-08-31End: 2012-11-30Updated: 2012-12-07

Related Papers

Exercise-mobilized lymphocytes enhance antibody-based immunotherapy in multiple myeloma through CD16+ NK cell–mediated cytotoxicity

Journal of Translational Medicine2026-03-03

Exercise-Mobilized Lymphocytes Enhance the Function of Cytokine-Induced Memory-like NK-cells Against Myeloid Leukemia.

2026-01-15